医共体药事质量同质化管理的应用研究

Objective This study investigated the feasibility and specific effects of implementing standardized pharmaceutical quality management within medical consortiums. Methods The effectiveness of pharmaceutical quality management in our hospital's pharmacy department was evaluated from December 2023 to November 2024. The period from December 2023 to May 2024 was designated as the “pre-implementation phase” for routine management, while June to November 2024 served as the “post-implementation phase” for standardized pharmaceutical quality management. Monthly systematic assessments were conducted on drug quality control inspections(covering pharmaceutical management, dynamic monitoring, rational drug use, and adverse drug reaction management) and standardized medication(including adherence to medication guidelines, process standardization, compatibility of Chinese and Western medicines, drug selection, and effectiveness of medication monitoring and feedback mechanisms). Each group underwent continuous evaluation for six months. Results After implementing standardized pharmaceutical quality management in medical consortiums, scores in drug quality control inspections were significantly higher than those in the pre-implementation phase, with statistically significant differences between the pre-implementation and post-implementation phases(P<0.05). Notably, standardized medication scores also demonstrated statistically significant improvements(P<0.05). Conclusion This study demonstrates that standardized pharmaceutical quality management in medical consortiums yields positive outcomes, significantly enhancing medication standardization and improving drug quality management efficiency in hospital pharmacies. These findings provide valuable references for broader implementation and promotion.